Codis officially launches as a new global CDMO specialising in commercial-scale spray drying, amorphous solid dispersions (ASD) and particle engineering technologies.
Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.
With facilities in St Louis, MO, Seymour, IN and Haverhill, UK, Codis offers the following:
- More than 5000 metric tons per year of spray drying output capacity
- Thirty products with 50 pharma global customers
- Thirty years of successful regulatory track record
- Audited and approved by 6 international regulatory agencies
- More than 300 employees worldwide.
"Codis is built on a foundation of scale, quality and global reach," said Nicolas Fortin, Codis CEO.
"With a total of 40,000 sqm of manufacturing space, three GMP facilities and with seven regulatory approvals achieved, we are uniquely positioned to help pharmaceutical innovators accelerate therapies from development to market."
Acquired from EUROAPI in June 2025, the Haverhill facility in the UK brings more than 30 years of expertise in spray drying, continuous flow chemistry and regulatory compliance.
The site also serves as one of the world's primary manufacturers of Sevelamer, underscoring its capability to support high-quality, globally approved products.